H.R. 7949: Plant Biological Research at the National Science Foundation Act
This bill, known as the Plant Biological Research at the National Science Foundation Act, aims to amend the National Science Foundation (NSF) Authorization Act of 2002. The primary focus of this legislation is to enhance support for research related to plant and microbial biology, particularly with significant implications for agriculture, food, and biotechnology sectors.
Key Provisions of the Bill
- The NSF will be able to award grants on a competitive basis to a variety of organizations. This includes:
- Institutions of higher education
- Nonprofit organizations
- Private sector entities
- Federal, State, local, or Tribal governments
- Consortia of the above-mentioned entities
- These grants will support research in the following areas:
- Fundamental research in plant biology
- Development of tools, resources, and technologies that advance plant biology
- The bill authorizes an appropriation of $150 million for each fiscal year from 2026 through 2031 specifically for this research initiative.
Definitions
The bill also includes an amendment to the definition of "nonprofit organization" within the context of the NSF Authorization Act. A nonprofit organization is defined as one that qualifies under section 501(c)(3) of the Internal Revenue Code, meaning it is recognized for tax-exempt purposes.
Goals of the Bill
The overarching goal of the bill is to promote scientific discovery and innovation in plant and microbial biology, which can lead to advancements in agricultural practices, food security, and biotechnology applications. By increasing funding and support for this area of research, the legislation aims to address critical challenges faced by these sectors.
Funding and Implementation
With an authorized budget set to be appropriated, the NSF will be equipped to facilitate and manage these research grants, fostering collaboration among academic institutions, nonprofit organizations, and private companies in the field of plant biology.
Relevant Companies
- Bayer AG (BAYRY): As a significant player in agriculture and biotechnology, Bayer could be impacted by advancements in plant biology research funding, affecting their product development and strategies in crop science.
- Dow Inc. (DOW): DOW, which is involved in agricultural solutions, may see changes in its operational landscape due to new research initiatives that could improve agricultural productivity through innovative bio-based methods.
- Corteva, Inc. (CTVA): As a major agriculture company, Corteva may benefit from new insights and technologies coming from the funded research, potentially influencing their product offerings and market strategies.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 16, 2026 | Introduced in House |
| Mar. 16, 2026 | Referred to the House Committee on Science, Space, and Technology. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.